Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?

Journal of Neural Transmission

Volumn 114, Issue 1, 2007, Pages 33-41

  Wu, H Q ^a   Rassoulpour, A ^a   Schwarcz, R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Alpha7 nicotinic; Aminooxyacetic acid; Astrocytes; Fluorocitrate; Gila neuron interactions; Kynurenine; Microdialysis; NMDA; Striatum

Indexed keywords

AMINOOXYACETIC ACID; BUNGAROTOXIN RECEPTOR; DEXTRO SERINE; DOPAMINE; FLUOROCITRIC ACID; GALANTAMINE; KYNURENIC ACID; KYNURENINE; KYNURENINE AMINOTRANSFERASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ASTROCYTE; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION KINETICS; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN; CELL COMMUNICATION; CORPUS STRIATUM; DOPAMINE; DOWN-REGULATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR SPACE; KYNURENIC ACID; MALE; NEURONS; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; TRANSAMINASES;

EID: 33845884834     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0562-y     Document Type: Conference Paper

References (72)

1. LF Agnati K Fuxe 2000 Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine Prog Brain Res 125 3 19
2. M Alkondon EF Pereira P Yu EZ Arruda LE Almeida P Guidetti WP Fawcett MT Sapko WR Randall R Schwarcz DA Tagle EX Albuquerque 2004 Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus J Neurosci 24 4635 4648
3. K Biziere JT Coyle 1979 Effects of cortical ablation on the neurotoxicity and receptor blinding of Kainic acid in striatum J Neurosci Res 4 383 398
4. LM Borland AC Michael 2004 Voltammetric study of the control of striatal dopamine release by glutamate J Neurochem 91 220 229
5. AC Bowling MF Beal 1995 Bioenergetic and oxidative stress in neurodegenerative diseases Life Sci 56 1151 1171
6. A Buisson V Pateau M Plotkine RG Boulu 1991 Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid Neurosci Lett 131 257 259
7. R Carpenedo A Chiarugi P Russi G Lombardi V Carlà R Pellicciari L Mattoli F Moroni 1994 Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities Neuroscience 61 237 244
8. R Carpenedo A Pittaluga A Cozzi S Attucci A Galli M Raiteri F Moroni 2001 Presynaptic kynurenate-sensitive receptors inhibit glutamate release Eur J Neurosci 13 2141 2147
9. G Ceresoli-Borroni P Guidetti R Schwarcz 1999 Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats J Neural Transm 106 229 242
10. A Cheramy R Romo G Godeheu P Baruch J Glowinski 1986 In vivo presynaptic control of dopamine release in the cat caudate nucleus-II. facilitatory or inhibitory influence of L-glutamate Neuroscience 19 1081 1090
11. A Cozzi R Carpenedo F Moroni 1999 Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxyl-[-N-4-(nitrophenyl)thiazol-2YL-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia J Cereb Blood Flow Metab 19 771 777
12. AE Csillik E Okuno B Csillik E Knyihar L Vécsei 2002 Expression of kynurenine aminotransferase in the subplate of the rat and its possible role in the regulation of programmed cell death Cereb Cortex 12 1193 1201
13. A Del Arco G Segovia K Fuxe F Mora 2003 Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J Neurochem 85 23 33
14. F Du W Schmidt E Okuno R Kido C Köhler R Schwarcz 1992 Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus J Comp Neurol 321 477 487
15. S Erhardt H Oberg G Engberg 2001a Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons Naunyn-Schmiedeberg's Arch Pharmacol 363 21 27
16. S Erhardt H Oberg JM Mathe G Engberg 2001b Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons Amino Acids 20 353 362
17. JG Greene JT Greenamyre 1996 Bioenergetics and glutamate excitotoxicity Prog Neurobiol 48 613 634
18. GJ Guillemin SJ Kerr GA Smythe DG Smith V Kapoor PJ Armati J Croitoru BJ Brew 2001 Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J Neurochem 78 842 853
19. E Hansson L Ronnback 2003 Glial neuronal signaling in the central nervous system FASEB J 17 341 348
20. CA Harris AF Miranda JJ Tanguay RJ Boegman RJ Beninger K Jhamandas 1998 Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid Br J Pharmacol 124 391 399
21. B Hassel RE Paulsen A Johnsen F Fonnum 1992 Selective inhibition of glial cell metabolism in vivo by fluorocitrate Brain Res 576 120 124
22. TG Hastings DA Lewis MJ Zigmond 1996 Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections Proc Natl Acad Sci USA 93 1956 1961
23. PG Haydon 2001 Glia: listening and talking to the synapse Nat Rev Neurosci 2 185 193
24. C Hilmas EF Pereira M Alkondon A Rassoulpour R Schwarcz EX Albuquerque 2001 The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J Neurosci 21 7463 7473
25. A Imperato T Honoré LH Jensen 1990 Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats Brain Res 530 223 228
26. RJ Jakel WF Maragos 2000 Neuronal cell death in Huntington's disease: a potential role for dopamine Trends Neurosci 23 239 245
27. S Kaiser S Wonnacott 2000 alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release Mol Pharmacol 58 312 318
28. M Kessler T Terramani G Lynch M Baudry 1989 A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists J Neurochem 52 1319 1328
29. Kettenmann H, Ransom BR (2004) Neuroglia, 2nd edition: 624
30. C Kiss G Ceresoli-Borroni P Guidetti CL Zielke HR Zielke R Schwarcz 2003 Kynurenate production by cultured human astrocytes J Neural Transm 110 1 14
31. V Leviel A Gobert B Guibert 1990 The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function Neuroscience 39 305 312
32. A Meldrum SB Dunnett BJ Everitt 2001 Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity Neuroreport 12 89 93
33. M Melendez-Ferro P Guidetti GE Hoffman R Schwarcz 2005 Immunocytochemical localization of kynurenine aminotransferase II in the rat brain Soc Neurosci Abstr 31 387.11
34. AF Miranda RJ Boegman RJ Beninger K Jhamandas 1997 Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid Neuroscience 78 967 975
35. B Moghaddam ML Bolinao 1994 Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release Synapse 18 337 342
36. F Moroni P Russi G Lombardi M Beni V Carlà 1988 Presence of kynurenic acid in the mammalian brain J Neurochem 51 177 180
37. F Moroni P Russi MA Gallo-Mezo G Moneti R Pellicciari 1991 Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine J Neurochem 57 1630 1635
38. F Moroni A Cozzi R Carpendo G Cipriani O Veneroni E Izzo 2005 Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus Neuropharmacology 48 788 795
39. DB Naritsin RL Boni SP Markey 1995 Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry Anal Chem 67 863 870
40. H Nishino H Hida M Kumazaki Y Shimano K Nakajima H Shimizu T Ooiwa H Baba 2000 The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability J Neurotrauma 17 251 260
41. SHR Oliet R Piet DA Poulain 2001 Control of glutamate clearance and synaptic efficacy by glial coverage of neurons Science 292 923 926
42. JW Olney LG Sharpe RD Feigin 1972 Glutamate-induced brain damage in infant primates J Neuropathol Exp Neurol 31 464 488
43. SP Onn AR West AA Grace 2000 Dopamine-mediated regulation of striatal neuronal and network interactions Trends Neurosci 23 S48 S56
44. JS Pakkanen E Jokitalo RK Tuominen 2005 Up-regulation of beta2 and alpha7 subunit containing nicotinic acetylcholine receptors in mouse striatum at cellular level Eur J Neurosci 21 2681 2691
45. 2+ oscillations in situ drive NMDAR-mediated neuronal excitation Nat Neurosci 4 803 812
46. CG Parsons W Danysz G Quack S Hartmann B Lorenz C Wollenburg L Baran E Przegalinski W Kostowski P Krzascik B Chizh PM Headley 1997 Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization J Pharmacol Exp Ther 283 1264 1275
47. RE Paulsen A Contestabile L Villani F Fonnum 1987 An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate J Neurochem 48 1377 1385
48. R Pellicciari B Natalini G Costantino MR Mahmoud L Mattoli BM Sadeghpour F Moroni A Chiarugi R Carpenedo 1994 Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase J Med Chem 37 647 655
49. MN Perkins TW Stone 1982 An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid Brain Res 247 184 187
50. A Rassoulpour HQ Wu B Poeggeler R Schwarcz 1998 Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain Brain Res 802 111 118
51. A Rassoulpour B Poeggeler C Kiss R Schwarcz 1999 Regulation of kynurenic acid synthesis and neuronal vulnerability to NMDA by acute administration of methylphenidate Soc Neurosci Abstr 25 229.11
52. A Rassoulpour HQ Wu S Ferré R Schwarcz 2005a Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum J Neurochem 93 762 765
53. A Rassoulpour HQ Wu R Schwarcz 2005b Nanomolar kynurenic acid blocks d-amphetamine-induced increase in extracellular dopamine in the rat striatum Soc Neurosci Abstr 31 664.18
54. R Rejdak E Zielinska Y Shenk WA Turski E Okuno T Zarnowski Z Zagorski E Zrenner K Kohler 2003 Ontogenic changes of kynurenine aminotransferase I activity and its expression in the chicken retina Vision Res 43 1513 1517
55. P Samadi L Gregoire A Rassoulpour P Guidetti E Izzo R Schwarcz P Bédard 2005 Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and anti-parkinsonian response to L-Dopa in parkinsonian monkeys Movement Dis 20 792 802
56. M Samochocki A Hoffle A Fehrenbacher R Jostock J Ludwig C Christner M Radina M Zerlin C Ullmer EF Pereira H Lubbert EX Albuquerque A Maelicke 2003 Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors J Pharmacol Exp Ther 305 1024 1036
57. MD Santos M Alkondon EF Pereira Y Aracava HM Eisenberg A Maelicke EX Albuquerque 2002 The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol Pharmacol 61 1222 1234
58. MT Sapko P Guidetti P Yu DA Tagle R Pellicciari R Schwarcz 2006 Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease Exp Neurol 197 31 40
59. MJ Schell 2004 The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective Philos Trans R Soc Lond B Biol Sci 359 943 964
60. R Schwarcz D Scholz JT Coyle 1978 Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues Neuropharmacology 17 145 151
61. R Schwarcz R Pellicciari 2002 Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J Pharmacol Exp Ther 303 1 10
62. C Speciale HQ Wu JB Gramsbergen WA Turski U Ungerstedt R Schwarcz 1990 Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid Neurosci Lett 116 198 203
63. MB Spina G Cohen 1989 Dopamine turnover and glutathione oxidation: implications for Parkinson disease Proc Natl Acad Sci USA 86 1398 1400
64. GF Tian H Azmi T Takano Q Xu W Peng J Lin N Oberheim N Lou X Wang HR Zielke J Kang M Nedergaard 2005 An astrocytic basis of epilepsy Nat Med 11 973 981
65. PN Tobler CD Fiorillo W Schultz 2005 Adaptive coding of reward value by dopamine neurons Science 307 1642 1645
66. WA Turski M Nakamura WP Todd BK Carpenter WO Whetsell Jr R Schwarcz 1988 Identification and quantification of kynurenic acid in human brain tissue Brain Res 454 164 169
67. WA Turski JB Gramsbergen H Traitler R Schwarcz 1989 Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine J Neurochem 52 1629 1636
68. A Volterra J Meldolesi 2005 Astrocytes, from brain glue to communication elements: the revolution continues Nat Rev Neurosci 6 626 640
69. ME Wolf X Sun S Mangiavacchi SZ Chao 2004 Psychomotor stimulants and neuronal plasticity Neuropharmacology 47 Suppl 1 61 79
70. HQ Wu H Baran U Ungerstedt R Schwarcz 1992 Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo Eur J Neurosci 4 1264 1270
71. HQ Wu P Guidetti R Schwarcz 2005 Extracellular kynurenic acid and dopamine in the striatum of mice with a deletion of kynurenine aminotransferase II Soc Neurosci Abstr 31 664.19
72. P Yu NA Di Prospero MT Sapko T Cai A Chen M Melendez-Ferro F Du WO Whetsell Jr P Guidetti R Schwarcz DA Tagle 2004 Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice Mol Cell Biol 24 6919 6930